U.S. drugmaker Pfizer is ready to launch its respiratory syncytial virus (RSV) vaccine for both older adults and pregnant women in the United States and Europe later this year, executives said on Thursday.

Europe will lose out to countries like the U.S. and Japan on new medical research, trials and treatments unless draft rules reforming the European pharmaceutical landscape change, the CEO of Danish drugmaker Novo Nordisk warned on Thursday.

European Commission President Ursula von der Leyen’s silence about her dealings with drugmaker Pfizer leading to the EU’s biggest COVID-19 vaccine contract is hurting public trust and is a problem that will not go away, its ombudsman said.

The European Cancer Imaging Initiative is an effort to speed up innovation and early cancer diagnosis using artificial intelligence.

Shortages of antibiotics have been reported in 26 European countries, according to the European Medicines Agency, in part due to the unseasonably early surge in respiratory infections.

U.S. life sciences company Illumina on Tuesday challenged an EU antitrust order to keep biotech firm Grail separate, ratcheting up its fight against EU regulators which blocked a merger deal last year.

The European Commission said on Friday it approved delaying the deadline for companies to comply with a new law regulating medical devices in order to prevent shortages of lifesaving equipment.

The European Union should consider immediately scaling up genomic sequencing of COVID-19 infections and monitoring of waste water, including from airports, to detect any new variants given the virus surge in China, the bloc’s health chief said.

Pfizer Inc. and its partner BioNTech said on Thursday the EU health regulator has recommended authorizing the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.

The European Commission has approved Sanofi and AstraZeneca’s Beyfortus for the prevention of a common and highly contagious type of respiratory infection in infants.